Skip to content
Independent supplement reviews
Metabolic Pantry
Reviews

Supplement review

5-HTP for Appetite & Carb Cravings: Does It Work?

5-HTP has real but old, small trials showing reduced appetite and carb intake via serotonin — plus genuine safety flags. An honest, evidence-first review.

Researched & rated by Hannah Cole, Supplements Research EditorIndependently rated on published evidenceLast updated

The verdict

Evidence-graded review

What we like

  • Claims traced to primary research or official labeling — not marketing copy.
  • Pricing and value assessed honestly, the way a buyer actually compares them.

Watch-outs

  • Supplement evidence is modest and mixed — treat any single result with caution.
  • A “natural GLP-1” supplement is not a GLP-1 medication.

5-HTP (5-hydroxytryptophan) is one of the few "natural" appetite supplements with actual randomized human trials behind it — which makes it both more interesting and more deserving of a careful look than most of the aisle. The catch is that the supportive studies are small, old, and run with a peripheral enzyme blocker most shoppers will never take, and the mechanism that makes 5-HTP work is the same one that makes it a real interaction and safety concern. Here is the honest accounting.

What 5-HTP is and how it's supposed to work

5-HTP is the immediate metabolic precursor of serotonin: your body converts dietary tryptophan to 5-HTP, then 5-HTP to serotonin. Supplements skip the first, rate-limiting step, so 5-HTP raises serotonin more readily than tryptophan does1. Serotonin, in turn, is one of the brain's satiety signals — serotonergic drugs were a mainstay of appetite pharmacology for decades, and the rationale for 5-HTP is simply to feed that pathway from the precursor end2.

That mechanism is real, not invented marketing. But "raises serotonin, and serotonin curbs appetite" is a chain of plausibility, not proof of weight loss — so the only question that matters is what controlled human trials actually found.

What the human trials actually showed

The supportive evidence for 5-HTP is a small cluster of Italian trials from the late 1980s and 1990s. They are genuinely positive, and worth taking seriously — but they are also dated and small.

In a 1989 study of obese women, oral 5-HTP reduced food intake and produced weight loss versus placebo over five weeks3. A 1992 randomized trial in obese adults found that 5-HTP led people to eat less, lose more weight, and — strikingly — adhere better to a prescribed diet, with an early reduction in carbohydrate intake and a sense of early satiety4. A later trial extended the same finding to people with non-insulin-dependent (type 2) diabetes: 5-HTP decreased energy and carbohydrate intake and reduced body weight5. Across these studies the consistent signal is reduced food intake — especially carbohydrate — and modest weight loss, plausibly through enhanced satiety1.

Strength of evidence

  • Reduced appetite / carbohydrate intakeMixed / modest

    Small, older randomized trials in obese adults; consistent direction.

  • Modest weight loss (with calorie restriction)Mixed / modest

    Same dated trials; no large modern replication.

  • Drug-like weight loss (GLP-1 scale)No good data

    No evidence; not a substitute for a weight-loss medication.

  • Safe to stack with serotonergic medsWeak / unproven

    Real serotonin-syndrome interaction risk — clear with a clinician.

Evidence is graded on controlled human trials, not mechanism or marketing.

So the appetite/carb-craving claim is not fabricated. Where you should be skeptical is in how far it generalizes. These trials were small, conducted by overlapping research groups, decades old, and several were paired with a calorie-restricted diet. There has been no modern, large, independent replication. A frequently-cited 1998 review summarizing 5-HTP as a "clinically effective serotonin precursor" usefully collects the early data, but it is a narrative review in a complementary-medicine journal, not a high-tier systematic review1 — treat it as a summary of old findings, not as strong contemporary evidence.

The carbidopa catch most labels skip

There is a pharmacological wrinkle that supplement marketing almost always omits. Several of the classic obesity trials gave 5-HTP without a decarboxylase inhibitor, but the broader 5-HTP literature — and its established use in neurology — pairs it with carbidopa, a peripheral enzyme blocker that stops 5-HTP from being converted to serotonin in the gut and bloodstream before it reaches the brain1. Without that blocker, a large share of an oral 5-HTP dose is converted peripherally, which both blunts the central effect and drives the most common side effect: nausea. The over-the-counter capsules you can buy contain no carbidopa, so they are not a clean match for the conditions of the most favorable studies.

Safety: the serotonin pathway cuts both ways

The same serotonin mechanism that gives 5-HTP its appetite effect is exactly why it is not a casual supplement.

The clearest concern is serotonin syndrome — a potentially life-threatening state of excess serotonergic activity (agitation, rapid heartbeat, high temperature, tremor, in severe cases) that arises when serotonergic agents are combined6. Because 5-HTP raises serotonin, stacking it with SSRIs, SNRIs, MAO inhibitors, certain migraine drugs (triptans), tramadol, dextromethorphan, or other serotonergic substances is a real and avoidable risk6. Anyone on an antidepressant should treat 5-HTP as a drug interaction, not a benign add-on, and talk to a clinician first.

Beyond interactions, the everyday tolerability issue is gastrointestinal — nausea is the dose-limiting complaint, again largely a consequence of peripheral serotonin production1. 5-HTP is also a supplement, so it sits outside the manufacturing oversight applied to approved drugs; historically, a related serotonin-precursor product (L-tryptophan) was tied to a serious illness traced to a manufacturing contaminant, which is part of why purity and sourcing matter for anything in this family.

Safety first

Before you try 5-HTP

  • Do not combine with SSRIs, SNRIs, MAO inhibitors, triptans, tramadol, or dextromethorphan — serotonin-syndrome risk.
  • Talk to a clinician first if you take any antidepressant or serotonergic medication.
  • Nausea is the most common side effect, driven by peripheral serotonin production.
  • OTC capsules contain no carbidopa, so they don't match the most favorable trial conditions.
  • It's a supplement — purity and sourcing matter; quality oversight is weaker than for approved drugs.
  • Best case it's a modest, satiety-leaning nudge — not a replacement for a GLP-1 medication.

How it stacks up against a GLP-1 drug

Put 5-HTP in proportion. Its best trials show reduced carbohydrate intake and a few pounds of weight loss in small, calorie-restricted studies. A GLP-1 medication operates on a different scale entirely — once-weekly semaglutide produced about 15% mean body-weight loss over 68 weeks in the STEP-1 trial7. 5-HTP is, at most, a modest appetite-leaning aid with real interaction risk; it is not a substitute for a weight-loss medication. For the full side-by-side, see our breakdown of supplements vs GLP-1 drugs.

The bottom line

5-HTP is unusual in this category: it has actual randomized trials suggesting it reduces appetite and carbohydrate intake and produces modest weight loss, with a coherent serotonin mechanism behind the effect345. But the evidence is old, small, largely un-replicated, and partly dependent on a carbidopa pairing the over-the-counter product doesn't include — and the serotonin pathway that drives any benefit is also a genuine safety and drug-interaction liability6. If you are not on any serotonergic medication and you want a modest, satiety-leaning nudge, it is one of the better-evidenced single ingredients here — but keep expectations small and clear the interaction question with a clinician first.

For where 5-HTP fits among food-first tools, see natural appetite suppressants that actually help; if sweet cravings specifically are the trigger, compare it with the ingredients we grade in supplements to stop sugar cravings; and for a non-serotonergic option aimed at stress eating, see whether ashwagandha helps weight via cortisol. For the whole evidence map of this category, start with our pillar, 'natural GLP-1' supplements: what the evidence shows, or jump to the vetted shortlist in best natural GLP-1 supplements.

Frequently asked questions

Does 5-HTP actually reduce appetite and carb cravings?

There is real, if old, trial support. Small randomized studies in obese adults found 5-HTP reduced food intake — especially carbohydrate — increased early satiety, and produced modest weight loss versus placebo. The effect is plausible via serotonin, but the studies are dated, small, largely un-replicated, and often paired with a calorie-restricted diet.

Is 5-HTP safe to take with antidepressants?

Treat it as a drug interaction, not a casual add-on. Because 5-HTP raises serotonin, combining it with SSRIs, SNRIs, MAO inhibitors, triptans, tramadol or dextromethorphan can risk serotonin syndrome, a potentially life-threatening reaction. If you take any serotonergic medication, talk to a clinician before using 5-HTP.

Why do the old studies use carbidopa but supplements don't?

Carbidopa is a peripheral enzyme blocker that stops 5-HTP from being converted to serotonin outside the brain, which improves central effect and reduces nausea. Over-the-counter 5-HTP capsules contain no carbidopa, so they don't fully match the conditions of the most favorable research, and more of the dose is converted peripherally.

Is 5-HTP as effective as Ozempic or Wegovy for weight loss?

No, not remotely. The best 5-HTP trials show reduced carb intake and a few pounds of weight loss in small, calorie-restricted studies. Once-weekly semaglutide produced about 15% mean body-weight loss in the STEP-1 trial. 5-HTP is at most a modest appetite-leaning aid, not a substitute for a GLP-1 medication.

References

  1. Birdsall TC (1998). 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative Medicine Review. https://pubmed.ncbi.nlm.nih.gov/9727088/
  2. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE (2007). Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs. https://pubmed.ncbi.nlm.nih.gov/17209663/
  3. Ceci F, Cangiano C, Cairella M, et al. (1989). The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. Journal of Neural Transmission. https://pubmed.ncbi.nlm.nih.gov/2468734/
  4. Cangiano C, Ceci F, Cascino A, et al. (1992). Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/1384305/
  5. Cangiano C, Laviano A, Del Ben M, et al. (1998). Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. International Journal of Obesity and Related Metabolic Disorders. https://pubmed.ncbi.nlm.nih.gov/9705024/
  6. Boyer EW, Shannon M (2005). The serotonin syndrome. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/15784664/
  7. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

More from the review desk